Chulmin Cho is currently a postdoctoral fellow in Dr. Loren Martin’s laboratory at the University of Toronto Mississauga. Chulmin earned my specialized BSc in Biochemistry with honours from York University in 2010, and his PhD in Neuroscience from McGill University in 2016, working with Dr. Lorraine Chalifour and Dr. Hemant Paudel. For his Ph.D thesis, he has uncovered Egr-1 transcription factor as a regulator of a dendritic spine protein called drebrin, which is known to be lost in Alzheimer’s disease leading to synapse loss. Currently, he is investigating opioid-mediated placebo analgesia in a mouse model of chronic neuropathic pain using pharmacological conditioning. His research will help deepen our understanding of the pathways involved in endogenous control of pain, and lead to discovery of better pain management strategies.